← Open Payments lookup

ROY DEL-ROSARIO: Open Payments

NPI 1740381870 · LANCASTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,859 in 165 payments from 15 companies in 2025. Trend: 2023 $3,104 · 2024 $2,782 · 2025 $2,859

Food & beverage: $2,859
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.29$549
Alkermes, Inc.27$398
Otsuka America Pharmaceutical, Inc.22$385
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$284
Lundbeck LLC13$226
E.R. Squibb & Sons, L.L.C.12$216
Takeda Pharmaceuticals U.S.A., Inc.13$154
ABBVIE INC.10$144
Teva Pharmaceuticals USA, Inc.5$141
Neurocrine BioSciences, Inc.5$102

Products named: REXULTI, Qelbree, ARISTADA, CAPLYTA, COBENFY, TRINTELLIX, VRAYLAR, INGREZZA.

Industry payments across CA — which companies pay providers there.